Come up with a name for your new list and we'll add to it:
Nanogenic Solutions was acquired by
Ryboquin on July 19, 2018.
Nanogenics is developing LipTide, an artificial virus, which acts as a custom-built delivery system that can be modified to target different cell types and deliver different payloads. LipTide is a pro…